Susceptibility of oral obligate anaerobes to telithromycin, moxifloxacin and a number of commonly used antibacterials

Oral Microbiology and Immunology

Volumn 22, Issue 5, 2007, Pages 298-303

  Tomas I ^a   Tomas M ^b   Alvarez M ^c   Velasco, D ^b   Potel, C ^c   Limeres, J ^a   Diz, P ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b HOSPITAL JUAN CANALEJO   (Spain)

^c HOSPITAL XERAL CÍES   (Spain)

Author keywords

Moxifloxacin; Obligate anaerobes; Oral flora; Telithromycin

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; AZITHROMYCIN; CLINDAMYCIN; METRONIDAZOLE; MOXIFLOXACIN; TELITHROMYCIN;

ADULT; ALLERGY; ANAEROBE; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; DENTISTRY; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG SENSITIVITY; HUMAN; INFECTION; PATHOGENESIS;

ADULT; AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; AZITHROMYCIN; BLOOD; CLINDAMYCIN; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE ANAEROBIC BACTERIA; HEMIN; HUMANS; KETOLIDES; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PERIODONTITIS; QUINOLINES; SALIVA; VITAMIN K;

EID: 34548304963     PISSN: 09020055     EISSN: 1399302X     Source Type: Journal    
DOI: 10.1111/j.1399-302X.2007.00359.x     Document Type: Article

References (35)

1. Ackerman G, Schaumann R, Pless B, Claros MC, Goldstein EJ, Rodloff AC. Comparative activity of moxifloxacin in vitro against obligate anaerobic bacteria. Eur J Clin Microbiol Infect Dis 2000 : 19 : 228 232.
2. American Dental Association, American Academy of Orthopaedic Surgeons. Antibiotic prophylaxis for dental patients with total joint replacements. J Am Dent Assoc 2003 : 134 : 895 899.
3. Bascones A, Aguirre JM, Bermejo A et al. Consensus statement on antimicrobial treatment of odontogenic bacterial infections. Med Oral Patol Oral Cir Bucal 2004 : 9 : 363 376.
4. Bisharat N, Goldstein L, Raz R, Elias M. Gram-negative anaerobic endocarditis: two case reports and review of the literature. Eur J Clin Microbiol Infect Dis 2001 : 20 : 651 654.
5. Brescó M, Costa N, Berini L, Gay C. Antibiotic susceptibility of the bacteria causing odontogenic infections. Med Oral Pathol Oral Cir Bucal 2006 : 11 : E70 E75.
6. Caeiro JP, Iannini PB. Moxifloxacin (Avelox): a novel fluoroquinolone with a broad spectrum of activity. Expert Rev Anti-Infect Ther 2003 : 1 : 363 370.
7. Dajani AS, Taubert KA, Wilson W et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. J Am Med Assoc 1997 : 277 : 1794 1801.
8. Eckert AW, Mauere P, Wilhelms D, Schubert J. Bacterial spectra and antibiotics in odontogenic infections. Renaissance of the penicillins? Mund Kiefer Gesichts Chir 2005 : 9 : 377 383.
9. Eick S, Pfister W, Straube E. Antimicrobial susceptibility of anaerobic and capnophilic bacteria isolated from odontogenic abscesses and rapidly progressive periodontitis. Int J Antimicrob Agents 1999 : 12 : 41 46.
10. Fosner L, Larsen T, Kilian M, Holmstrup P. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol 2006 : 33 : 401 407.
11. Gilbert DN, Moellering RC, Eliopoulos GM, Sande MA. The Sanford guide to antimicrobial therapy, 35th edn. Sperryville, VA : Antimicrobial Therapy, Inc., 2005.
12. Goldstein EJC, Citron DM, Merriam CV, Warren Y, Tyrrel KL, Fernandez H. In vitro activities of telithromycin and 10 oral agents against aerobic and anaerobic pathogens isolated from antral puncture specimens from patients with sinusitis. Antimicrob Agents Chemother 2003 : 47 : 1963 1967.
13. Gould FK, Elliot TSJ, Foweraker J et al. Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2006 : 57 : 1035 1042.
14. Goumas PD, Naxakis SS, Papavasiliou DA, Moschovakis ED, Tsintsos SJ, Skoutelis A. Periapical abscesses: causal bacteria and antibiotic sensitivity. J Chemother 1997 : 9 : 415 419.
15. Handal T, Olsen I, Walker CB, Caugant DA. β-Lactamase production and antimicrobial susceptibility of subgingival bacteria from refractory periodontitis. Oral Microbiol Immunol 2004 : 19 : 303 308.
16. Jacinto RC, Gomes BP, Ferraz CC, Zaia AA, Filho FJ. Microbiological analysis of infected root canals from symptomatic and asymptomatic teeth with periapical periodontitis and the antimicrobial susceptibility of some isolated anaerobic bacteria. Oral Microbiol Immunol 2003 : 18 : 285 292.
17. Johnson AP. Telithromycin. Aventis Pharma. Curr Opin Investig Drugs 2001 : 2 : 1691 1701.
18. Khemaleelakul S, Baumgartner C, Pruksakorn S. Identification of bacteria in acute endodontic infections and their antimicrobial susceptibility. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002 : 94 : 746 755.
19. Kinane DF, Riggio MP, Walker KF, MacKenzie D, Shearer B. Bacteraemia following periodontal procedures. J Clin Peridontol 2005 : 32 : 708 713.
20. Kuriyama T, Karasawa T, Nakagawa K, Saiki Y, Yamamoto E, Nakamura S. Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000 : 90 : 600 608.
21. Kuriyama T, Karasawa T, Nakagawa K, Yamamoto E, Nakamura S. Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections. Oral Microbiol Immunol 2002 : 17 : 132 135.
22. Lewis MAO, Parkhurst CL, Douglas CWI et al. Prevalence of penicillin resistant bacteria in acute suppurative oral infection. J Antimicrob Chemother 1995 : 35 : 785 791.
23. Milazzo I, Blandino G, Musumeci R, Nicoletti G, Lo Bue AM, Speciale A. Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections. Int J Antimicrob Agents 2002 : 20 : 451 456.
24. Miravitlles M. Moxifloxacin in respiratory tract infections. Expert Opin Pharmacother 2005 : 6 : 283 293.
25. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, ed. Manual of clinical microbiology, 7th edn. Washington, DC : American Society for Microbiology, 1999.
26. NCCLS. Performance standards for antimicrobial susceptibility testing, 14th informational supplement. NCCLS document M100-S14 (ISBN 1-56238-516-X). Wayne, PN : NCCLS, 2004.
27. NCCLS. Methods for antimicrobial susceptibility testing of anaerobic bacteria, approved standard, 6th edn. NCCLS document M11-A6 (ISBN 1-56238-517-8). Wayne, PA : NCCLS, 2004.
28. Rasmussen BA, Bush K, Tally FP. Antimicrobial resistance in anaerobes. Clin Infect Dis 1997 : 24 (suppl 1 S110 S120.
29. Ready D, Bedi R, Spratt DA, Mullany P, Wilson M. Prevalence, proportions, and identities of antibiotic-resistant bacteria in the oral microflora of healthy children. Microb Drug Resist 2003 : 9 : 367 372.
30. Sixou JL, Magaud C, Jolivet-Gougeon A, Cormier M, Bonnaure-Mallet M. Evaluation of the mandibular third molar pericoronitis flora and its susceptibility to different antibiotics prescribed in France. J Clin Microbiol 2003 : 41 : 5794 5797.
31. Sobottka I, Cachovan G, Stürenburg E et al. In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses. Antimicrob Agents Chemother 2002 : 46 : 4019 4021.
32. Spiers KM, Zervos MJ. Telithromycin. Expert Rev Anti-Infect Ther 2004 : 2 : 685 693.
33. Tanner A, Stillman N. Oral and dental infections with anaerobic bacteria: clinical features, predominant pathogens, and treatment. Clin Infect Dis 1993 : 16 (suppl 4 S304 S309.
34. Van Winkelhoff AJ, Gonzales DH, Winkel EG, Dellemijn-Kippuw N, Vandenbroucke-Grauls CMJE, Sanz M. Antimicrobial resistance in the subgingival microflora in patients with adult periodontitis. J Clin Periodontol 2000 : 27 : 79 86.
35. Wexler HM, Molitoris E, Molitoris D, Finegold SM. In vitro activity of telithromycin (HMR 3647) against 502 strains of anaerobic bacteria. J Antimicrob Chemother 2001 : 47 : 467 469.